Worth reading
41Recurring
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
490000
Shares (decrease in potential shares)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Extinguishment of trust-type stock options (stock acquisition rights)
Terms of the stock acquisition rights
Exercise price
¥897 per share (18th and 19th Series; after adjustment in connection with the third-party allotment capital increase for which the payment date was 1 December 2025)
Exercise period
18th Series: from 1 April 2021 to 29 November 2029; 19th Series: from 1 April 2022 to 29 November 2030
Number of Stock Acquisition Rights
18th Series: 2,450 (all to be extinguished); 19th Series: 2,450 (all to be extinguished)
Reason for acquisition without consideration
No beneficiaries were designated, and the trustee will waive all of the rights in accordance with the agreement
Conditions on transfer restrictions
Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.
Conditions for lifting transfer restrictions
Meeting the performance assessment thresholds was prescribed as a condition for exercising the rights, but neither threshold was met
Intended allottee's holding policy
The trustee will waive all of these stock acquisition rights
Procedures under the Corporate Code of Conduct
As the settlor is a director of the Company, approval was obtained from the Board of Directors in accordance with procedures comparable to those for transactions involving conflicts of interest
Most recent equity financing
Third-party allotment capital increase for which the payment date was 1 December 2025 (including an adjustment to the exercise price)
Impact on Business Performance
The Company expects to record a ¥490,000 gain on reversal of stock acquisition rights as an extraordinary gain in the fiscal year ending December 2026. The impact on earnings will be immaterial. The number of potential shares will decrease by 490,000
| Item | Details |
|---|---|
| Type of issuance or disposal | Extinguishment of trust-type stock options (stock acquisition rights) |
| Intended allottee's holding policy | The trustee will waive all of these stock acquisition rights |
| Exercise price | ¥897 per share (18th and 19th Series; after adjustment in connection with the third-party allotment capital increase for which the payment date was 1 December 2025) |
| Exercise period | 18th Series: from 1 April 2021 to 29 November 2029; 19th Series: from 1 April 2022 to 29 November 2030 |
| Number of Stock Acquisition Rights | 18th Series: 2,450 (all to be extinguished); 19th Series: 2,450 (all to be extinguished) |
| Conditions for lifting transfer restrictions | Meeting the performance assessment thresholds was prescribed as a condition for exercising the rights, but neither threshold was met |
| Reason for acquisition without consideration | No beneficiaries were designated, and the trustee will waive all of the rights in accordance with the agreement |
| Procedures under the Corporate Code of Conduct | As the settlor is a director of the Company, approval was obtained from the Board of Directors in accordance with procedures comparable to those for transactions involving conflicts of interest |
| Most recent equity financing | Third-party allotment capital increase for which the payment date was 1 December 2025 (including an adjustment to the exercise price) |
| Impact on Business Performance | The Company expects to record a ¥490,000 gain on reversal of stock acquisition rights as an extraordinary gain in the fiscal year ending December 2026. The impact on earnings will be immaterial. The number of potential shares will decrease by 490,000 |
Items this document does not state (18)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because no beneficiaries were designated when the delivery criteria were assessed and the performance assessment thresholds were not met, the stock acquisition rights remained unexercised, making it difficult to expect them to fulfill their incentive function as stock options.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.